AFC-HD AMS Life Science Co. Ltd. (2927.TO) | ||
Japan | ||
Year Ended August 31 | ||
GROUP | 2024 | 2023 |
Revenue | Y30.19 bln | Y25.58 bln |
Operating Profit | Y1.92 bln | Y1.64 bln |
Pretax Profit | Y1.92 bln | Y1.65 bln |
Net Profit | Y1.24 bln | Y1.10 bln |
Per share | ||
Earnings | Y88.64 | Y78.51 |
Diluted Earnings | Y88.54 | Y78.46 |
Results are based on Japanese accounting standards. |
This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(MORE TO FOLLOW) Dow Jones Newswires
October 15, 2024 02:00 ET (06:00 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。